I was quoted!
We recently learned that our local oncologist is retiring. He’s 52 years old and has had it with the medical profession, citing increasing difficulties with insurance companies and litigious Americans as a few of the reasons for early retirement. I’m really going to miss him. He was probably the best doctor I ever had in my life. He shoots straight from the hip and tells it like it is.
I’ll continue with my quarterly visits to Duke and will see the replacement doctor at this local practice every few months.
No blood was drawn, so it’ll be September before I have any test results to share again. In the mean time, I’ll assume I’m still stable and myeloma will stay in the deeper recesses of my mind. It’s been a pleasure to have been treatment free for almost a year now. I still have myeloma, but it’s been sitting still.
ScienceDaily (2008-07-28) — An international team of scientists has identified processes that are heavily implicated in human multiple myeloma and other B cell cancers, moving us closer to developing quick tests and readouts that could help in the tailored treatment of patients.
“We already know that the over-expression or mutation of molecules known as NIK and TRAF3 in B cells is associated with human multiple myeloma,” said Professor Mackay. “Our collaborative research uncovered two distinct processes involving these molecules that help explain why.”